Delayed Danish state Covid vaccine to be trialled on humans in 2022
National Danish infectious disease research organization Statens Serum Institut has found a manufacturer for its in-house Covid-19 vaccine, moving it closer to testing the candidate on human subjects following a series of delays.
BY RITZAU, TRANSLATED BY DANIEL FRANK CHRISTENSEN
Denmark's second coronavirus vaccine, Covaxix, which is being developed by National Danish infectious disease research organization Statens Serum Insitut (SSI), has come closer to being tested on humans in phase I and II trials in 2022 after a string of delays.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
